Please login or register to print this page.


Articles tagged ‘RE-LY’

August 5, 2014

Persistently high cardiac biomarkers important in AF

Persistent elevation of troponin and the N-terminal prohormone of brain natriuretic peptide (NT-proBNP) indicates a worse prognosis than transient elevations or no elevations of either marker, according to a study published recently in Heart.1

read more

September 27, 2012

ESC Congress 2012 roundup

In our latest Expert Opinion podcast, Professor Keith Fox (BHF Duke of Edinburgh Chair of Cardiology, Edinburgh University) sums up new data from the RE-LY and ARISTOTLE trials presented recently at the European Society of Cardiology (ESC) Congress in Munich, Germany.

read more

April 18, 2012

New oral anticoagulants eclipse warfarin in cost savings

Usage of the new oral anticoagulants (NOACs), dabigatran, rivaroxaban, and apixaban, may be associated with lower medical costs (excluding drug costs) relative to warfarin, according to results from the RE-LY, ROCKET-AF, and ARISTOTLE clinical trials. These were presented at the American College of Cardiology’s (ACC’s) 61st Annual Scientific Session, held recently in Chicago.

read more

September 20, 2010

Dabigatran Features In New AF Guidelines

The new European Society of Cardiology (ESC)guidelines for the management of atrial fibrillation (AF), have now included guidance on the role of a novel oral treatment, dabigatran etexilate, for the prevention of stroke and systemic embolism in patients with AF (1)

read more

March 22, 2010

New RE-LY data presented at ACC

New sub-group analysis from the landmark RE-LY study has shown dabigatran etexilate significantly reduces the risk of stroke compared to warfarin irrespective of a patient’s risk profile for stroke.

read more

Members Area

Log in or Register now.



Subscribe to our RSS feed


Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.


    None Found


  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.